#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Dysbalanced Resting-State Functional Connectivity Within the Praxis Network Is Linked to Gesture Deficits in Schizophrenia Abstract Patients with schizophrenia frequently present deficits in gesture production and interpretation, greatly affecting their communication skills.
1-1	0-11	Dysbalanced	_
1-2	12-25	Resting-State	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-3	26-36	Functional	_
1-4	37-49	Connectivity	_
1-5	50-56	Within	_
1-6	57-60	the	_
1-7	61-67	Praxis	_
1-8	68-75	Network	_
1-9	76-78	Is	_
1-10	79-85	Linked	_
1-11	86-88	to	_
1-12	89-96	Gesture	_
1-13	97-105	Deficits	_
1-14	106-108	in	_
1-15	109-122	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-16	123-131	Abstract	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-17	132-140	Patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-18	141-145	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-19	146-159	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-20	160-170	frequently	_
1-21	171-178	present	_
1-22	179-187	deficits	_
1-23	188-190	in	_
1-24	191-198	gesture	_
1-25	199-209	production	_
1-26	210-213	and	_
1-27	214-228	interpretation	_
1-28	229-230	,	_
1-29	231-238	greatly	_
1-30	239-248	affecting	_
1-31	249-254	their	_
1-32	255-268	communication	_
1-33	269-275	skills	_
1-34	276-277	.	_

Text=As these gesture deficits can be found early in the course of illness and as they can predict later outcomes, exploring their neural basis may lead to a better understanding of schizophrenia.
2-1	278-280	As	_
2-2	281-286	these	_
2-3	287-294	gesture	_
2-4	295-303	deficits	_
2-5	304-307	can	_
2-6	308-310	be	_
2-7	311-316	found	_
2-8	317-322	early	_
2-9	323-325	in	_
2-10	326-329	the	_
2-11	330-336	course	_
2-12	337-339	of	_
2-13	340-347	illness	_
2-14	348-351	and	_
2-15	352-354	as	_
2-16	355-359	they	_
2-17	360-363	can	_
2-18	364-371	predict	_
2-19	372-377	later	_
2-20	378-386	outcomes	_
2-21	387-388	,	_
2-22	389-398	exploring	_
2-23	399-404	their	_
2-24	405-411	neural	_
2-25	412-417	basis	_
2-26	418-421	may	_
2-27	422-426	lead	_
2-28	427-429	to	_
2-29	430-431	a	_
2-30	432-438	better	_
2-31	439-452	understanding	_
2-32	453-455	of	_
2-33	456-469	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-34	470-471	.	_

Text=While gesturing has been reported to rely on a left lateralized network of brain regions, termed praxis network, in healthy subjects and lesioned patients, studies in patients with schizophrenia are sparse.
3-1	472-477	While	_
3-2	478-487	gesturing	_
3-3	488-491	has	_
3-4	492-496	been	_
3-5	497-505	reported	_
3-6	506-508	to	_
3-7	509-513	rely	_
3-8	514-516	on	_
3-9	517-518	a	_
3-10	519-523	left	_
3-11	524-535	lateralized	_
3-12	536-543	network	_
3-13	544-546	of	_
3-14	547-552	brain	_
3-15	553-560	regions	_
3-16	561-562	,	_
3-17	563-569	termed	_
3-18	570-576	praxis	_
3-19	577-584	network	_
3-20	585-586	,	_
3-21	587-589	in	_
3-22	590-597	healthy	_
3-23	598-606	subjects	_
3-24	607-610	and	_
3-25	611-619	lesioned	_
3-26	620-628	patients	_
3-27	629-630	,	_
3-28	631-638	studies	_
3-29	639-641	in	_
3-30	642-650	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-31	651-655	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-32	656-669	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-33	670-673	are	_
3-34	674-680	sparse	_
3-35	681-682	.	_

Text=It is currently unclear whether within-network connectivity at rest is linked to gesture deficit.
4-1	683-685	It	_
4-2	686-688	is	_
4-3	689-698	currently	_
4-4	699-706	unclear	_
4-5	707-714	whether	_
4-6	715-729	within-network	_
4-7	730-742	connectivity	_
4-8	743-745	at	_
4-9	746-750	rest	_
4-10	751-753	is	_
4-11	754-760	linked	_
4-12	761-763	to	_
4-13	764-771	gesture	_
4-14	772-779	deficit	_
4-15	780-781	.	_

Text=Here, we compared the functional connectivity between regions of the praxis network at rest between 46 patients and 44 healthy controls.
5-1	782-786	Here	_
5-2	787-788	,	_
5-3	789-791	we	_
5-4	792-800	compared	_
5-5	801-804	the	_
5-6	805-815	functional	_
5-7	816-828	connectivity	_
5-8	829-836	between	_
5-9	837-844	regions	_
5-10	845-847	of	_
5-11	848-851	the	_
5-12	852-858	praxis	_
5-13	859-866	network	_
5-14	867-869	at	_
5-15	870-874	rest	_
5-16	875-882	between	_
5-17	883-885	46	_
5-18	886-894	patients	_
5-19	895-898	and	_
5-20	899-901	44	_
5-21	902-909	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-22	910-918	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-23	919-920	.	_

Text=All participants completed a validated test of hand gesture performance before resting-state functional magnetic resonance imaging (fMRI) was acquired.
6-1	921-924	All	_
6-2	925-937	participants	_
6-3	938-947	completed	_
6-4	948-949	a	_
6-5	950-959	validated	_
6-6	960-964	test	_
6-7	965-967	of	_
6-8	968-972	hand	_
6-9	973-980	gesture	_
6-10	981-992	performance	_
6-11	993-999	before	_
6-12	1000-1013	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-13	1014-1024	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-14	1025-1033	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-15	1034-1043	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-16	1044-1051	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-17	1052-1053	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-18	1054-1058	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-19	1059-1060	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-20	1061-1064	was	_
6-21	1065-1073	acquired	_
6-22	1074-1075	.	_

Text=Patients performed gestures poorer than controls in all categories and domains.
7-1	1076-1084	Patients	_
7-2	1085-1094	performed	_
7-3	1095-1103	gestures	_
7-4	1104-1110	poorer	_
7-5	1111-1115	than	_
7-6	1116-1124	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
7-7	1125-1127	in	_
7-8	1128-1131	all	_
7-9	1132-1142	categories	_
7-10	1143-1146	and	_
7-11	1147-1154	domains	_
7-12	1155-1156	.	_

Text=In patients, we also found significantly higher resting-state functional connectivity between left precentral gyrus and bilateral superior and inferior parietal lobule.
8-1	1157-1159	In	_
8-2	1160-1168	patients	_
8-3	1169-1170	,	_
8-4	1171-1173	we	_
8-5	1174-1178	also	_
8-6	1179-1184	found	_
8-7	1185-1198	significantly	_
8-8	1199-1205	higher	_
8-9	1206-1219	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
8-10	1220-1230	functional	_
8-11	1231-1243	connectivity	_
8-12	1244-1251	between	_
8-13	1252-1256	left	_
8-14	1257-1267	precentral	_
8-15	1268-1273	gyrus	_
8-16	1274-1277	and	_
8-17	1278-1287	bilateral	_
8-18	1288-1296	superior	_
8-19	1297-1300	and	_
8-20	1301-1309	inferior	_
8-21	1310-1318	parietal	_
8-22	1319-1325	lobule	_
8-23	1326-1327	.	_

Text=Likewise, patients had higher connectivity from right precentral gyrus to left inferior and bilateral superior parietal lobule (SPL).
9-1	1328-1336	Likewise	_
9-2	1337-1338	,	_
9-3	1339-1347	patients	_
9-4	1348-1351	had	_
9-5	1352-1358	higher	_
9-6	1359-1371	connectivity	_
9-7	1372-1376	from	_
9-8	1377-1382	right	_
9-9	1383-1393	precentral	_
9-10	1394-1399	gyrus	_
9-11	1400-1402	to	_
9-12	1403-1407	left	_
9-13	1408-1416	inferior	_
9-14	1417-1420	and	_
9-15	1421-1430	bilateral	_
9-16	1431-1439	superior	_
9-17	1440-1448	parietal	_
9-18	1449-1455	lobule	_
9-19	1456-1457	(	_
9-20	1458-1461	SPL	_
9-21	1462-1463	)	_
9-22	1464-1465	.	_

Text=In contrast, they exhibited lower connectivity between bilateral superior temporal gyrus (STG).
10-1	1466-1468	In	_
10-2	1469-1477	contrast	_
10-3	1478-1479	,	_
10-4	1480-1484	they	_
10-5	1485-1494	exhibited	_
10-6	1495-1500	lower	_
10-7	1501-1513	connectivity	_
10-8	1514-1521	between	_
10-9	1522-1531	bilateral	_
10-10	1532-1540	superior	_
10-11	1541-1549	temporal	_
10-12	1550-1555	gyrus	_
10-13	1556-1557	(	_
10-14	1558-1561	STG	_
10-15	1562-1563	)	_
10-16	1564-1565	.	_

Text=Connectivity between right precentral gyrus and left SPL, as well as connectivity between bilateral STG, correlated with gesture performance in healthy controls.
11-1	1566-1578	Connectivity	_
11-2	1579-1586	between	_
11-3	1587-1592	right	_
11-4	1593-1603	precentral	_
11-5	1604-1609	gyrus	_
11-6	1610-1613	and	_
11-7	1614-1618	left	_
11-8	1619-1622	SPL	_
11-9	1623-1624	,	_
11-10	1625-1627	as	_
11-11	1628-1632	well	_
11-12	1633-1635	as	_
11-13	1636-1648	connectivity	_
11-14	1649-1656	between	_
11-15	1657-1666	bilateral	_
11-16	1667-1670	STG	_
11-17	1671-1672	,	_
11-18	1673-1683	correlated	_
11-19	1684-1688	with	_
11-20	1689-1696	gesture	_
11-21	1697-1708	performance	_
11-22	1709-1711	in	_
11-23	1712-1719	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
11-24	1720-1728	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
11-25	1729-1730	.	_

Text=We failed to detect similar correlations in patients.
12-1	1731-1733	We	_
12-2	1734-1740	failed	_
12-3	1741-1743	to	_
12-4	1744-1750	detect	_
12-5	1751-1758	similar	_
12-6	1759-1771	correlations	_
12-7	1772-1774	in	_
12-8	1775-1783	patients	_
12-9	1784-1785	.	_

Text=We suggest that altered resting-state functional connectivity within the praxis network perturbs correct gesture planning in patients, reflecting the gesture deficit often seen in schizophrenia.
13-1	1786-1788	We	_
13-2	1789-1796	suggest	_
13-3	1797-1801	that	_
13-4	1802-1809	altered	_
13-5	1810-1823	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
13-6	1824-1834	functional	_
13-7	1835-1847	connectivity	_
13-8	1848-1854	within	_
13-9	1855-1858	the	_
13-10	1859-1865	praxis	_
13-11	1866-1873	network	_
13-12	1874-1882	perturbs	_
13-13	1883-1890	correct	_
13-14	1891-1898	gesture	_
13-15	1899-1907	planning	_
13-16	1908-1910	in	_
13-17	1911-1919	patients	_
13-18	1920-1921	,	_
13-19	1922-1932	reflecting	_
13-20	1933-1936	the	_
13-21	1937-1944	gesture	_
13-22	1945-1952	deficit	_
13-23	1953-1958	often	_
13-24	1959-1963	seen	_
13-25	1964-1966	in	_
13-26	1967-1980	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-27	1981-1982	.	_

Text=Methods Participants We included 46 patients with schizophrenia spectrum disorders and 44 age-, sex-, and education-matched healthy controls.
14-1	1983-1990	Methods	_
14-2	1991-2003	Participants	_
14-3	2004-2006	We	_
14-4	2007-2015	included	_
14-5	2016-2018	46	_
14-6	2019-2027	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-7	2028-2032	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-8	2033-2046	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-9	2047-2055	spectrum	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-10	2056-2065	disorders	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-11	2066-2069	and	_
14-12	2070-2072	44	_
14-13	2073-2077	age-	_
14-14	2078-2079	,	_
14-15	2080-2084	sex-	_
14-16	2085-2086	,	_
14-17	2087-2090	and	_
14-18	2091-2108	education-matched	_
14-19	2109-2116	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
14-20	2117-2125	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
14-21	2126-2127	.	_

Text=We have published behavioral data and fMRI task analyses in these participants before (eg,).
15-1	2128-2130	We	_
15-2	2131-2135	have	_
15-3	2136-2145	published	_
15-4	2146-2156	behavioral	_
15-5	2157-2161	data	_
15-6	2162-2165	and	_
15-7	2166-2170	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
15-8	2171-2175	task	_
15-9	2176-2184	analyses	_
15-10	2185-2187	in	_
15-11	2188-2193	these	_
15-12	2194-2206	participants	_
15-13	2207-2213	before	_
15-14	2214-2215	(	_
15-15	2216-2218	eg	_
15-16	2219-2220	,	_
15-17	2221-2222	)	_
15-18	2223-2224	.	_

Text=Patients were recruited from inpatient and outpatient departments of University Hospital of Psychiatry, Bern, Switzerland.
16-1	2225-2233	Patients	_
16-2	2234-2238	were	_
16-3	2239-2248	recruited	_
16-4	2249-2253	from	_
16-5	2254-2263	inpatient	_
16-6	2264-2267	and	_
16-7	2268-2278	outpatient	_
16-8	2279-2290	departments	_
16-9	2291-2293	of	_
16-10	2294-2304	University	_
16-11	2305-2313	Hospital	_
16-12	2314-2316	of	_
16-13	2317-2327	Psychiatry	_
16-14	2328-2329	,	_
16-15	2330-2334	Bern	_
16-16	2335-2336	,	_
16-17	2337-2348	Switzerland	_
16-18	2349-2350	.	_

Text=Controls were recruited among staff and via advertisements.
17-1	2351-2359	Controls	_
17-2	2360-2364	were	_
17-3	2365-2374	recruited	_
17-4	2375-2380	among	_
17-5	2381-2386	staff	_
17-6	2387-2390	and	_
17-7	2391-2394	via	_
17-8	2395-2409	advertisements	_
17-9	2410-2411	.	_

Text=Exclusion criteria for both groups were substance abuse or dependence other than nicotine, current or history of medical conditions impairing movements, epilepsy, history of head trauma with loss of consciousness, and history of electroconvulsive therapy.
18-1	2412-2421	Exclusion	_
18-2	2422-2430	criteria	_
18-3	2431-2434	for	_
18-4	2435-2439	both	_
18-5	2440-2446	groups	_
18-6	2447-2451	were	_
18-7	2452-2461	substance	_
18-8	2462-2467	abuse	_
18-9	2468-2470	or	_
18-10	2471-2481	dependence	_
18-11	2482-2487	other	_
18-12	2488-2492	than	_
18-13	2493-2501	nicotine	_
18-14	2502-2503	,	_
18-15	2504-2511	current	_
18-16	2512-2514	or	_
18-17	2515-2522	history	_
18-18	2523-2525	of	_
18-19	2526-2533	medical	_
18-20	2534-2544	conditions	_
18-21	2545-2554	impairing	_
18-22	2555-2564	movements	_
18-23	2565-2566	,	_
18-24	2567-2575	epilepsy	_
18-25	2576-2577	,	_
18-26	2578-2585	history	_
18-27	2586-2588	of	_
18-28	2589-2593	head	_
18-29	2594-2600	trauma	_
18-30	2601-2605	with	_
18-31	2606-2610	loss	_
18-32	2611-2613	of	_
18-33	2614-2627	consciousness	_
18-34	2628-2629	,	_
18-35	2630-2633	and	_
18-36	2634-2641	history	_
18-37	2642-2644	of	_
18-38	2645-2662	electroconvulsive	_
18-39	2663-2670	therapy	_
18-40	2671-2672	.	_

Text=Patients fulfilled DSM-5 criteria for schizophrenia, schizoaffective disorder, or schizophreniform disorder.
19-1	2673-2681	Patients	_
19-2	2682-2691	fulfilled	_
19-3	2692-2697	DSM-5	_
19-4	2698-2706	criteria	_
19-5	2707-2710	for	_
19-6	2711-2724	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
19-7	2725-2726	,	_
19-8	2727-2742	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
19-9	2743-2751	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
19-10	2752-2753	,	_
19-11	2754-2756	or	_
19-12	2757-2773	schizophreniform	http://maven.renci.org/NeuroBridge/neurobridge#SchizophreniformDisorder
19-13	2774-2782	disorder	http://maven.renci.org/NeuroBridge/neurobridge#SchizophreniformDisorder
19-14	2783-2784	.	_

Text=Diagnosis was ensured using the Mini International Neuropsychiatric Interview and Comprehensive Assessment of Symptoms and History.
20-1	2785-2794	Diagnosis	_
20-2	2795-2798	was	_
20-3	2799-2806	ensured	_
20-4	2807-2812	using	_
20-5	2813-2816	the	_
20-6	2817-2821	Mini	_
20-7	2822-2835	International	_
20-8	2836-2852	Neuropsychiatric	http://maven.renci.org/NeuroBridge/neurobridge#MentalHealthDiagnosisScale
20-9	2853-2862	Interview	http://maven.renci.org/NeuroBridge/neurobridge#MentalHealthDiagnosisScale
20-10	2863-2866	and	_
20-11	2867-2880	Comprehensive	_
20-12	2881-2891	Assessment	_
20-13	2892-2894	of	_
20-14	2895-2903	Symptoms	_
20-15	2904-2907	and	_
20-16	2908-2915	History	_
20-17	2916-2917	.	_

Text=Controls with a history of any psychiatric disorder or first-degree relatives with schizophrenia or schizoaffective disorder were excluded.
21-1	2918-2926	Controls	_
21-2	2927-2931	with	_
21-3	2932-2933	a	_
21-4	2934-2941	history	_
21-5	2942-2944	of	_
21-6	2945-2948	any	_
21-7	2949-2960	psychiatric	_
21-8	2961-2969	disorder	_
21-9	2970-2972	or	_
21-10	2973-2985	first-degree	_
21-11	2986-2995	relatives	_
21-12	2996-3000	with	_
21-13	3001-3014	schizophrenia	_
21-14	3015-3017	or	_
21-15	3018-3033	schizoaffective	_
21-16	3034-3042	disorder	_
21-17	3043-3047	were	_
21-18	3048-3056	excluded	_
21-19	3057-3058	.	_

Text=All participants were right-handed according to the Edinburgh Handedness Inventory.We employed the Frontal Assessment Battery (FAB) and the Test of nonverbal Intelligence (TONI) in all participants, as well as the Positive and Negative Syndrome Scale (PANSS), the Abnormal Involuntary Movement Scale (AIMS), and the Bush-Francis Catatonia Rating Scale (BFCRS) in patients.
22-1	3059-3062	All	_
22-2	3063-3075	participants	_
22-3	3076-3080	were	_
22-4	3081-3093	right-handed	_
22-5	3094-3103	according	_
22-6	3104-3106	to	_
22-7	3107-3110	the	_
22-8	3111-3120	Edinburgh	_
22-9	3121-3131	Handedness	_
22-10	3132-3144	Inventory.We	_
22-11	3145-3153	employed	_
22-12	3154-3157	the	_
22-13	3158-3165	Frontal	http://maven.renci.org/NeuroBridge/neurobridge#FrontalAssessmentBattery
22-14	3166-3176	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#FrontalAssessmentBattery
22-15	3177-3184	Battery	http://maven.renci.org/NeuroBridge/neurobridge#FrontalAssessmentBattery
22-16	3185-3186	(	http://maven.renci.org/NeuroBridge/neurobridge#FrontalAssessmentBattery
22-17	3187-3190	FAB	http://maven.renci.org/NeuroBridge/neurobridge#FrontalAssessmentBattery
22-18	3191-3192	)	http://maven.renci.org/NeuroBridge/neurobridge#FrontalAssessmentBattery
22-19	3193-3196	and	_
22-20	3197-3200	the	_
22-21	3201-3205	Test	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
22-22	3206-3208	of	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
22-23	3209-3218	nonverbal	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
22-24	3219-3231	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
22-25	3232-3233	(	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
22-26	3234-3238	TONI	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
22-27	3239-3240	)	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
22-28	3241-3243	in	_
22-29	3244-3247	all	_
22-30	3248-3260	participants	_
22-31	3261-3262	,	_
22-32	3263-3265	as	_
22-33	3266-3270	well	_
22-34	3271-3273	as	_
22-35	3274-3277	the	_
22-36	3278-3286	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-37	3287-3290	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-38	3291-3299	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-39	3300-3308	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-40	3309-3314	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-41	3315-3316	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-42	3317-3322	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-43	3323-3324	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-44	3325-3326	,	_
22-45	3327-3330	the	_
22-46	3331-3339	Abnormal	http://maven.renci.org/NeuroBridge/neurobridge#AbnormalInvoluntaryMovementScale
22-47	3340-3351	Involuntary	http://maven.renci.org/NeuroBridge/neurobridge#AbnormalInvoluntaryMovementScale
22-48	3352-3360	Movement	http://maven.renci.org/NeuroBridge/neurobridge#AbnormalInvoluntaryMovementScale
22-49	3361-3366	Scale	http://maven.renci.org/NeuroBridge/neurobridge#AbnormalInvoluntaryMovementScale
22-50	3367-3368	(	http://maven.renci.org/NeuroBridge/neurobridge#AbnormalInvoluntaryMovementScale
22-51	3369-3373	AIMS	http://maven.renci.org/NeuroBridge/neurobridge#AbnormalInvoluntaryMovementScale
22-52	3374-3375	)	http://maven.renci.org/NeuroBridge/neurobridge#AbnormalInvoluntaryMovementScale
22-53	3376-3377	,	_
22-54	3378-3381	and	_
22-55	3382-3385	the	_
22-56	3386-3398	Bush-Francis	http://maven.renci.org/NeuroBridge/neurobridge#FrancisCatatoniaRatingScale
22-57	3399-3408	Catatonia	http://maven.renci.org/NeuroBridge/neurobridge#FrancisCatatoniaRatingScale
22-58	3409-3415	Rating	http://maven.renci.org/NeuroBridge/neurobridge#FrancisCatatoniaRatingScale
22-59	3416-3421	Scale	http://maven.renci.org/NeuroBridge/neurobridge#FrancisCatatoniaRatingScale
22-60	3422-3423	(	http://maven.renci.org/NeuroBridge/neurobridge#FrancisCatatoniaRatingScale
22-61	3424-3429	BFCRS	http://maven.renci.org/NeuroBridge/neurobridge#FrancisCatatoniaRatingScale
22-62	3430-3431	)	http://maven.renci.org/NeuroBridge/neurobridge#FrancisCatatoniaRatingScale
22-63	3432-3434	in	_
22-64	3435-3443	patients	_
22-65	3444-3445	.	_

Text=Written informed consent was obtained from all participants.
23-1	3446-3453	Written	_
23-2	3454-3462	informed	_
23-3	3463-3470	consent	_
23-4	3471-3474	was	_
23-5	3475-3483	obtained	_
23-6	3484-3488	from	_
23-7	3489-3492	all	_
23-8	3493-3505	participants	_
23-9	3506-3507	.	_

Text=The study protocol adhered to the Declaration of Helsinki and was approved by the local Ethics Committee.
24-1	3508-3511	The	_
24-2	3512-3517	study	_
24-3	3518-3526	protocol	_
24-4	3527-3534	adhered	_
24-5	3535-3537	to	_
24-6	3538-3541	the	_
24-7	3542-3553	Declaration	_
24-8	3554-3556	of	_
24-9	3557-3565	Helsinki	_
24-10	3566-3569	and	_
24-11	3570-3573	was	_
24-12	3574-3582	approved	_
24-13	3583-3585	by	_
24-14	3586-3589	the	_
24-15	3590-3595	local	_
24-16	3596-3602	Ethics	_
24-17	3603-3612	Committee	_
24-18	3613-3614	.	_

Text=Gesture Assessment We evaluated gesture performance using the Test of Upper Limb Apraxia (TULIA).
25-1	3615-3622	Gesture	_
25-2	3623-3633	Assessment	_
25-3	3634-3636	We	_
25-4	3637-3646	evaluated	_
25-5	3647-3654	gesture	_
25-6	3655-3666	performance	_
25-7	3667-3672	using	_
25-8	3673-3676	the	_
25-9	3677-3681	Test	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
25-10	3682-3684	of	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
25-11	3685-3690	Upper	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
25-12	3691-3695	Limb	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
25-13	3696-3703	Apraxia	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
25-14	3704-3705	(	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
25-15	3706-3711	TULIA	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
25-16	3712-3713	)	http://maven.renci.org/NeuroBridge/neurobridge#TestofNonverbalIntelligence
25-17	3714-3715	.	_

Text=It consists of 48 items divided into imitation (upon demonstration) and pantomime (upon verbal command) domains.
26-1	3716-3718	It	_
26-2	3719-3727	consists	_
26-3	3728-3730	of	_
26-4	3731-3733	48	_
26-5	3734-3739	items	_
26-6	3740-3747	divided	_
26-7	3748-3752	into	_
26-8	3753-3762	imitation	_
26-9	3763-3764	(	_
26-10	3765-3769	upon	_
26-11	3770-3783	demonstration	_
26-12	3784-3785	)	_
26-13	3786-3789	and	_
26-14	3790-3799	pantomime	_
26-15	3800-3801	(	_
26-16	3802-3806	upon	_
26-17	3807-3813	verbal	_
26-18	3814-3821	command	_
26-19	3822-3823	)	_
26-20	3824-3831	domains	_
26-21	3832-3833	.	_

Text=Both domains are further divided into 3 semantic categories: meaningless (gesture-like movements without semantic content), intransitive (communicative, non-object related), and transitive (object-related) gestures.
27-1	3834-3838	Both	_
27-2	3839-3846	domains	_
27-3	3847-3850	are	_
27-4	3851-3858	further	_
27-5	3859-3866	divided	_
27-6	3867-3871	into	_
27-7	3872-3873	3	_
27-8	3874-3882	semantic	_
27-9	3883-3893	categories	_
27-10	3894-3895	:	_
27-11	3896-3907	meaningless	_
27-12	3908-3909	(	_
27-13	3910-3922	gesture-like	_
27-14	3923-3932	movements	_
27-15	3933-3940	without	_
27-16	3941-3949	semantic	_
27-17	3950-3957	content	_
27-18	3958-3959	)	_
27-19	3960-3961	,	_
27-20	3962-3974	intransitive	_
27-21	3975-3976	(	_
27-22	3977-3990	communicative	_
27-23	3991-3992	,	_
27-24	3993-4003	non-object	_
27-25	4004-4011	related	_
27-26	4012-4013	)	_
27-27	4014-4015	,	_
27-28	4016-4019	and	_
27-29	4020-4030	transitive	_
27-30	4031-4032	(	_
27-31	4033-4047	object-related	_
27-32	4048-4049	)	_
27-33	4050-4058	gestures	_
27-34	4059-4060	.	_

Text=Each item is scored on a 0–5 scale resulting in a maximum of 240 points.
28-1	4061-4065	Each	_
28-2	4066-4070	item	_
28-3	4071-4073	is	_
28-4	4074-4080	scored	_
28-5	4081-4083	on	_
28-6	4084-4085	a	_
28-7	4086-4089	0–5	_
28-8	4090-4095	scale	_
28-9	4096-4105	resulting	_
28-10	4106-4108	in	_
28-11	4109-4110	a	_
28-12	4111-4118	maximum	_
28-13	4119-4121	of	_
28-14	4122-4125	240	_
28-15	4126-4132	points	_
28-16	4133-4134	.	_

Text=Higher score indicates better performance.
29-1	4135-4141	Higher	_
29-2	4142-4147	score	_
29-3	4148-4157	indicates	_
29-4	4158-4164	better	_
29-5	4165-4176	performance	_
29-6	4177-4178	.	_

Text=The Test was recorded on video and analyzed by a rater who was blind to diagnoses following the TULIA scoring manual.
30-1	4179-4182	The	_
30-2	4183-4187	Test	_
30-3	4188-4191	was	_
30-4	4192-4200	recorded	_
30-5	4201-4203	on	_
30-6	4204-4209	video	_
30-7	4210-4213	and	_
30-8	4214-4222	analyzed	_
30-9	4223-4225	by	_
30-10	4226-4227	a	_
30-11	4228-4233	rater	_
30-12	4234-4237	who	_
30-13	4238-4241	was	_
30-14	4242-4247	blind	_
30-15	4248-4250	to	_
30-16	4251-4260	diagnoses	_
30-17	4261-4270	following	_
30-18	4271-4274	the	_
30-19	4275-4280	TULIA	_
30-20	4281-4288	scoring	_
30-21	4289-4295	manual	_
30-22	4296-4297	.	_

Text=To test laterality, the TULIA was performed bilaterally.
31-1	4298-4300	To	_
31-2	4301-4305	test	_
31-3	4306-4316	laterality	_
31-4	4317-4318	,	_
31-5	4319-4322	the	_
31-6	4323-4328	TULIA	_
31-7	4329-4332	was	_
31-8	4333-4342	performed	_
31-9	4343-4354	bilaterally	_
31-10	4355-4356	.	_

Text=Image Acquisition We then acquired structural and functional imaging data.
32-1	4357-4362	Image	_
32-2	4363-4374	Acquisition	_
32-3	4375-4377	We	_
32-4	4378-4382	then	_
32-5	4383-4391	acquired	_
32-6	4392-4402	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
32-7	4403-4406	and	_
32-8	4407-4417	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
32-9	4418-4425	imaging	_
32-10	4426-4430	data	_
32-11	4431-4432	.	_

Text=Imaging was conducted at the Institute of Neuroradiology at University Hospital of Bern on a 3T Siemens Magnetom Trio scanner (Siemens Medical Solutions) on the same day as the gesture behavior assessments.
33-1	4433-4440	Imaging	_
33-2	4441-4444	was	_
33-3	4445-4454	conducted	_
33-4	4455-4457	at	_
33-5	4458-4461	the	_
33-6	4462-4471	Institute	_
33-7	4472-4474	of	_
33-8	4475-4489	Neuroradiology	_
33-9	4490-4492	at	_
33-10	4493-4503	University	_
33-11	4504-4512	Hospital	_
33-12	4513-4515	of	_
33-13	4516-4520	Bern	_
33-14	4521-4523	on	_
33-15	4524-4525	a	_
33-16	4526-4528	3T	_
33-17	4529-4536	Siemens	_
33-18	4537-4545	Magnetom	_
33-19	4546-4550	Trio	_
33-20	4551-4558	scanner	_
33-21	4559-4560	(	_
33-22	4561-4568	Siemens	_
33-23	4569-4576	Medical	_
33-24	4577-4586	Solutions	_
33-25	4587-4588	)	_
33-26	4589-4591	on	_
33-27	4592-4595	the	_
33-28	4596-4600	same	_
33-29	4601-4604	day	_
33-30	4605-4607	as	_
33-31	4608-4611	the	_
33-32	4612-4619	gesture	_
33-33	4620-4628	behavior	_
33-34	4629-4640	assessments	_
33-35	4641-4642	.	_

Text=First, we acquired structural T1-weighted modified driven equilibrium Fourier transform (MDEFT) images with 176 sagittal slices, matrix size of 256 × 256, FOV 256 × 256, yielding a voxel size of 1 × 1 × 1mm, repetition time (TR) 7.92 ms, echo time (TE) 2.48 ms, inversion time (TI) 910 ms and flip angle of 16°.
34-1	4643-4648	First	_
34-2	4649-4650	,	_
34-3	4651-4653	we	_
34-4	4654-4662	acquired	_
34-5	4663-4673	structural	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
34-6	4674-4685	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
34-7	4686-4694	modified	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
34-8	4695-4701	driven	_
34-9	4702-4713	equilibrium	_
34-10	4714-4721	Fourier	_
34-11	4722-4731	transform	_
34-12	4732-4733	(	_
34-13	4734-4739	MDEFT	_
34-14	4740-4741	)	_
34-15	4742-4748	images	_
34-16	4749-4753	with	_
34-17	4754-4757	176	_
34-18	4758-4766	sagittal	_
34-19	4767-4773	slices	_
34-20	4774-4775	,	_
34-21	4776-4782	matrix	_
34-22	4783-4787	size	_
34-23	4788-4790	of	_
34-24	4791-4794	256	_
34-25	4795-4796	×	_
34-26	4797-4800	256	_
34-27	4801-4802	,	_
34-28	4803-4806	FOV	_
34-29	4807-4810	256	_
34-30	4811-4812	×	_
34-31	4813-4816	256	_
34-32	4817-4818	,	_
34-33	4819-4827	yielding	_
34-34	4828-4829	a	_
34-35	4830-4835	voxel	_
34-36	4836-4840	size	_
34-37	4841-4843	of	_
34-38	4844-4845	1	_
34-39	4846-4847	×	_
34-40	4848-4849	1	_
34-41	4850-4851	×	_
34-42	4852-4855	1mm	_
34-43	4856-4857	,	_
34-44	4858-4868	repetition	_
34-45	4869-4873	time	_
34-46	4874-4875	(	_
34-47	4876-4878	TR	_
34-48	4879-4880	)	_
34-49	4881-4885	7.92	_
34-50	4886-4888	ms	_
34-51	4889-4890	,	_
34-52	4891-4895	echo	_
34-53	4896-4900	time	_
34-54	4901-4902	(	_
34-55	4903-4905	TE	_
34-56	4906-4907	)	_
34-57	4908-4912	2.48	_
34-58	4913-4915	ms	_
34-59	4916-4917	,	_
34-60	4918-4927	inversion	_
34-61	4928-4932	time	_
34-62	4933-4934	(	_
34-63	4935-4937	TI	_
34-64	4938-4939	)	_
34-65	4940-4943	910	_
34-66	4944-4946	ms	_
34-67	4947-4950	and	_
34-68	4951-4955	flip	_
34-69	4956-4961	angle	_
34-70	4962-4964	of	_
34-71	4965-4968	16°	_
34-72	4969-4970	.	_

Text=Second, we acquired a set of 256 functional BOLD T2 * images with 38 transverse slices, matrix dimensions 64 × 64, FOV 230 × 230, yielding a voxel size of 3.59 × 3.59 × 3mm, TR 2000 ms resulting in 8.5 min sequence duration, TE 30 ms, flip angle 90°.
35-1	4971-4977	Second	_
35-2	4978-4979	,	_
35-3	4980-4982	we	_
35-4	4983-4991	acquired	_
35-5	4992-4993	a	_
35-6	4994-4997	set	_
35-7	4998-5000	of	_
35-8	5001-5004	256	_
35-9	5005-5015	functional	_
35-10	5016-5020	BOLD	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
35-11	5021-5023	T2	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
35-12	5024-5025	*	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
35-13	5026-5032	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
35-14	5033-5037	with	_
35-15	5038-5040	38	_
35-16	5041-5051	transverse	_
35-17	5052-5058	slices	_
35-18	5059-5060	,	_
35-19	5061-5067	matrix	_
35-20	5068-5078	dimensions	_
35-21	5079-5081	64	_
35-22	5082-5083	×	_
35-23	5084-5086	64	_
35-24	5087-5088	,	_
35-25	5089-5092	FOV	_
35-26	5093-5096	230	_
35-27	5097-5098	×	_
35-28	5099-5102	230	_
35-29	5103-5104	,	_
35-30	5105-5113	yielding	_
35-31	5114-5115	a	_
35-32	5116-5121	voxel	_
35-33	5122-5126	size	_
35-34	5127-5129	of	_
35-35	5130-5134	3.59	_
35-36	5135-5136	×	_
35-37	5137-5141	3.59	_
35-38	5142-5143	×	_
35-39	5144-5147	3mm	_
35-40	5148-5149	,	_
35-41	5150-5152	TR	_
35-42	5153-5157	2000	_
35-43	5158-5160	ms	_
35-44	5161-5170	resulting	_
35-45	5171-5173	in	_
35-46	5174-5177	8.5	_
35-47	5178-5181	min	_
35-48	5182-5190	sequence	_
35-49	5191-5199	duration	_
35-50	5200-5201	,	_
35-51	5202-5204	TE	_
35-52	5205-5207	30	_
35-53	5208-5210	ms	_
35-54	5211-5212	,	_
35-55	5213-5217	flip	_
35-56	5218-5223	angle	_
35-57	5224-5227	90°	_
35-58	5228-5229	.	_

Text=Preprocessing Preprocessing and analysis of imaging data were performed in CONN-toolbox (15.h, www.nitrc.org/projects/conn) for MATLAB (R2015a, MathWorks).
36-1	5230-5243	Preprocessing	_
36-2	5244-5257	Preprocessing	_
36-3	5258-5261	and	_
36-4	5262-5270	analysis	_
36-5	5271-5273	of	_
36-6	5274-5281	imaging	_
36-7	5282-5286	data	_
36-8	5287-5291	were	_
36-9	5292-5301	performed	_
36-10	5302-5304	in	_
36-11	5305-5317	CONN-toolbox	_
36-12	5318-5319	(	_
36-13	5320-5324	15.h	_
36-14	5325-5326	,	_
36-15	5327-5354	www.nitrc.org/projects/conn	_
36-16	5355-5356	)	_
36-17	5357-5360	for	_
36-18	5361-5367	MATLAB	_
36-19	5368-5369	(	_
36-20	5370-5376	R2015a	_
36-21	5377-5378	,	_
36-22	5379-5388	MathWorks	_
36-23	5389-5390	)	_
36-24	5391-5392	.	_

Text=We used its standard pipeline for preprocessing.
37-1	5393-5395	We	_
37-2	5396-5400	used	_
37-3	5401-5404	its	_
37-4	5405-5413	standard	_
37-5	5414-5422	pipeline	_
37-6	5423-5426	for	_
37-7	5427-5440	preprocessing	_
37-8	5441-5442	.	_

Text=This included segmentation and normalization of structural images to MNI template as well as slice-timing correction, realignment and unwarping, normalization to MNI space, coregistration to structural image, and smoothing with a Gaussian 8 mm FWHM kernel of functional images.
38-1	5443-5447	This	_
38-2	5448-5456	included	_
38-3	5457-5469	segmentation	_
38-4	5470-5473	and	_
38-5	5474-5487	normalization	_
38-6	5488-5490	of	_
38-7	5491-5501	structural	_
38-8	5502-5508	images	_
38-9	5509-5511	to	_
38-10	5512-5515	MNI	_
38-11	5516-5524	template	_
38-12	5525-5527	as	_
38-13	5528-5532	well	_
38-14	5533-5535	as	_
38-15	5536-5548	slice-timing	_
38-16	5549-5559	correction	_
38-17	5560-5561	,	_
38-18	5562-5573	realignment	_
38-19	5574-5577	and	_
38-20	5578-5587	unwarping	_
38-21	5588-5589	,	_
38-22	5590-5603	normalization	_
38-23	5604-5606	to	_
38-24	5607-5610	MNI	_
38-25	5611-5616	space	_
38-26	5617-5618	,	_
38-27	5619-5633	coregistration	_
38-28	5634-5636	to	_
38-29	5637-5647	structural	_
38-30	5648-5653	image	_
38-31	5654-5655	,	_
38-32	5656-5659	and	_
38-33	5660-5669	smoothing	_
38-34	5670-5674	with	_
38-35	5675-5676	a	_
38-36	5677-5685	Gaussian	_
38-37	5686-5687	8	_
38-38	5688-5690	mm	_
38-39	5691-5695	FWHM	_
38-40	5696-5702	kernel	_
38-41	5703-5705	of	_
38-42	5706-5716	functional	_
38-43	5717-5723	images	_
38-44	5724-5725	.	_

Text=Resulting images were detrended.
39-1	5726-5735	Resulting	_
39-2	5736-5742	images	_
39-3	5743-5747	were	_
39-4	5748-5757	detrended	_
39-5	5758-5759	.	_

Text=We then performed subject-wise first-level analyses to account for white matter and cerebrospinal fluid signal, movement parameters, and outliers, which were detected using ART-toolbox (11-06, https: //www.nitrc.org/projects/artifact_detect) included in CONN (global-signal Z-threshold: 9, subject motion thresholds: 2 mm, 0.02 rad).
40-1	5760-5762	We	_
40-2	5763-5767	then	_
40-3	5768-5777	performed	_
40-4	5778-5790	subject-wise	_
40-5	5791-5802	first-level	_
40-6	5803-5811	analyses	_
40-7	5812-5814	to	_
40-8	5815-5822	account	_
40-9	5823-5826	for	_
40-10	5827-5832	white	_
40-11	5833-5839	matter	_
40-12	5840-5843	and	_
40-13	5844-5857	cerebrospinal	_
40-14	5858-5863	fluid	_
40-15	5864-5870	signal	_
40-16	5871-5872	,	_
40-17	5873-5881	movement	_
40-18	5882-5892	parameters	_
40-19	5893-5894	,	_
40-20	5895-5898	and	_
40-21	5899-5907	outliers	_
40-22	5908-5909	,	_
40-23	5910-5915	which	_
40-24	5916-5920	were	_
40-25	5921-5929	detected	_
40-26	5930-5935	using	_
40-27	5936-5947	ART-toolbox	_
40-28	5948-5949	(	_
40-29	5950-5955	11-06	_
40-30	5956-5957	,	_
40-31	5958-5963	https	_
40-32	5964-5965	:	_
40-33	5966-6006	//www.nitrc.org/projects/artifact_detect	_
40-34	6007-6008	)	_
40-35	6009-6017	included	_
40-36	6018-6020	in	_
40-37	6021-6025	CONN	_
40-38	6026-6027	(	_
40-39	6028-6041	global-signal	_
40-40	6042-6053	Z-threshold	_
40-41	6054-6055	:	_
40-42	6056-6057	9	_
40-43	6058-6059	,	_
40-44	6060-6067	subject	_
40-45	6068-6074	motion	_
40-46	6075-6085	thresholds	_
40-47	6086-6087	:	_
40-48	6088-6089	2	_
40-49	6090-6092	mm	_
40-50	6093-6094	,	_
40-51	6095-6099	0.02	_
40-52	6100-6103	rad	_
40-53	6104-6105	)	_
40-54	6106-6107	.	_

Text=Finally, resulting timelines were band-pass filtered between 0.008 and 0.09 Hz.
41-1	6108-6115	Finally	_
41-2	6116-6117	,	_
41-3	6118-6127	resulting	_
41-4	6128-6137	timelines	_
41-5	6138-6142	were	_
41-6	6143-6152	band-pass	_
41-7	6153-6161	filtered	_
41-8	6162-6169	between	_
41-9	6170-6175	0.008	_
41-10	6176-6179	and	_
41-11	6180-6184	0.09	_
41-12	6185-6187	Hz	_
41-13	6188-6189	.	_

Text=Selection of Seed Regions We chose 11 ROIs for each hemisphere and used the gray matter (GM) Brodmann Area masks and the automated anatomical labeling (AAL) atlas in the Statistic Parametric Mapping (SPM) 12 (www.fil.ion.ucl.ac.uk/spm).
42-1	6190-6199	Selection	_
42-2	6200-6202	of	_
42-3	6203-6207	Seed	_
42-4	6208-6215	Regions	_
42-5	6216-6218	We	_
42-6	6219-6224	chose	_
42-7	6225-6227	11	_
42-8	6228-6232	ROIs	_
42-9	6233-6236	for	_
42-10	6237-6241	each	_
42-11	6242-6252	hemisphere	_
42-12	6253-6256	and	_
42-13	6257-6261	used	_
42-14	6262-6265	the	_
42-15	6266-6270	gray	_
42-16	6271-6277	matter	_
42-17	6278-6279	(	_
42-18	6280-6282	GM	_
42-19	6283-6284	)	_
42-20	6285-6293	Brodmann	_
42-21	6294-6298	Area	_
42-22	6299-6304	masks	_
42-23	6305-6308	and	_
42-24	6309-6312	the	_
42-25	6313-6322	automated	_
42-26	6323-6333	anatomical	_
42-27	6334-6342	labeling	_
42-28	6343-6344	(	_
42-29	6345-6348	AAL	_
42-30	6349-6350	)	_
42-31	6351-6356	atlas	_
42-32	6357-6359	in	_
42-33	6360-6363	the	_
42-34	6364-6373	Statistic	_
42-35	6374-6384	Parametric	_
42-36	6385-6392	Mapping	_
42-37	6393-6394	(	_
42-38	6395-6398	SPM	_
42-39	6399-6400	)	_
42-40	6401-6403	12	_
42-41	6404-6405	(	_
42-42	6406-6431	www.fil.ion.ucl.ac.uk/spm	_
42-43	6432-6433	)	_
42-44	6434-6435	.	_

Text=The selection of these ROIs is based on structural and functional findings in healthy participants and patients with schizophrenia.
43-1	6436-6439	The	_
43-2	6440-6449	selection	_
43-3	6450-6452	of	_
43-4	6453-6458	these	_
43-5	6459-6463	ROIs	_
43-6	6464-6466	is	_
43-7	6467-6472	based	_
43-8	6473-6475	on	_
43-9	6476-6486	structural	_
43-10	6487-6490	and	_
43-11	6491-6501	functional	_
43-12	6502-6510	findings	_
43-13	6511-6513	in	_
43-14	6514-6521	healthy	_
43-15	6522-6534	participants	_
43-16	6535-6538	and	_
43-17	6539-6547	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
43-18	6548-6552	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
43-19	6553-6566	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
43-20	6567-6568	.	_

Text=The ROIs included the bilateral insula, IPL, SPL, supramarginal gyrus, MTG, STG, IFG subdivided into pars opercularis, triangularis and orbitalis, superior frontal gyrus, and precentral gyrus.
44-1	6569-6572	The	_
44-2	6573-6577	ROIs	_
44-3	6578-6586	included	_
44-4	6587-6590	the	_
44-5	6591-6600	bilateral	_
44-6	6601-6607	insula	_
44-7	6608-6609	,	_
44-8	6610-6613	IPL	_
44-9	6614-6615	,	_
44-10	6616-6619	SPL	_
44-11	6620-6621	,	_
44-12	6622-6635	supramarginal	_
44-13	6636-6641	gyrus	_
44-14	6642-6643	,	_
44-15	6644-6647	MTG	_
44-16	6648-6649	,	_
44-17	6650-6653	STG	_
44-18	6654-6655	,	_
44-19	6656-6659	IFG	_
44-20	6660-6670	subdivided	_
44-21	6671-6675	into	_
44-22	6676-6680	pars	_
44-23	6681-6692	opercularis	_
44-24	6693-6694	,	_
44-25	6695-6707	triangularis	_
44-26	6708-6711	and	_
44-27	6712-6721	orbitalis	_
44-28	6722-6723	,	_
44-29	6724-6732	superior	_
44-30	6733-6740	frontal	_
44-31	6741-6746	gyrus	_
44-32	6747-6748	,	_
44-33	6749-6752	and	_
44-34	6753-6763	precentral	_
44-35	6764-6769	gyrus	_
44-36	6770-6771	.	_

Text=Statistical Models Statistical analyses of clinical data were performed in IBM SPSS version 24.
45-1	6772-6783	Statistical	_
45-2	6784-6790	Models	_
45-3	6791-6802	Statistical	_
45-4	6803-6811	analyses	_
45-5	6812-6814	of	_
45-6	6815-6823	clinical	_
45-7	6824-6828	data	_
45-8	6829-6833	were	_
45-9	6834-6843	performed	_
45-10	6844-6846	in	_
45-11	6847-6850	IBM	_
45-12	6851-6855	SPSS	_
45-13	6856-6863	version	_
45-14	6864-6866	24	_
45-15	6867-6868	.	_

Text=Between-group sex differences were calculated using a Chi-square test.
46-1	6869-6882	Between-group	_
46-2	6883-6886	sex	_
46-3	6887-6898	differences	_
46-4	6899-6903	were	_
46-5	6904-6914	calculated	_
46-6	6915-6920	using	_
46-7	6921-6922	a	_
46-8	6923-6933	Chi-square	_
46-9	6934-6938	test	_
46-10	6939-6940	.	_

Text=We tested age, education, TONI, and FAB for normal distribution with Shapiro-Wilk tests and compared these variables between groups using 2-sample t-tests or Mann-Whitney U tests where appropriate.
47-1	6941-6943	We	_
47-2	6944-6950	tested	_
47-3	6951-6954	age	_
47-4	6955-6956	,	_
47-5	6957-6966	education	_
47-6	6967-6968	,	_
47-7	6969-6973	TONI	_
47-8	6974-6975	,	_
47-9	6976-6979	and	_
47-10	6980-6983	FAB	_
47-11	6984-6987	for	_
47-12	6988-6994	normal	_
47-13	6995-7007	distribution	_
47-14	7008-7012	with	_
47-15	7013-7025	Shapiro-Wilk	_
47-16	7026-7031	tests	_
47-17	7032-7035	and	_
47-18	7036-7044	compared	_
47-19	7045-7050	these	_
47-20	7051-7060	variables	_
47-21	7061-7068	between	_
47-22	7069-7075	groups	_
47-23	7076-7081	using	_
47-24	7082-7090	2-sample	_
47-25	7091-7098	t-tests	_
47-26	7099-7101	or	_
47-27	7102-7114	Mann-Whitney	_
47-28	7115-7116	U	_
47-29	7117-7122	tests	_
47-30	7123-7128	where	_
47-31	7129-7140	appropriate	_
47-32	7141-7142	.	_

Text=We have previously investigated group differences and presentation/semantic effects of the TULIA scores of this sample using a repeated-measures ANOVA.
48-1	7143-7145	We	_
48-2	7146-7150	have	_
48-3	7151-7161	previously	_
48-4	7162-7174	investigated	_
48-5	7175-7180	group	_
48-6	7181-7192	differences	_
48-7	7193-7196	and	_
48-8	7197-7218	presentation/semantic	_
48-9	7219-7226	effects	_
48-10	7227-7229	of	_
48-11	7230-7233	the	_
48-12	7234-7239	TULIA	_
48-13	7240-7246	scores	_
48-14	7247-7249	of	_
48-15	7250-7254	this	_
48-16	7255-7261	sample	_
48-17	7262-7267	using	_
48-18	7268-7269	a	_
48-19	7270-7287	repeated-measures	_
48-20	7288-7293	ANOVA	_
48-21	7294-7295	.	_

Text=Here, we also tested side (left or right hand) as possible within-subject factor in addition to domain (imitation or pantomime) and category (transitive, intransitive, or meaningless).
49-1	7296-7300	Here	_
49-2	7301-7302	,	_
49-3	7303-7305	we	_
49-4	7306-7310	also	_
49-5	7311-7317	tested	_
49-6	7318-7322	side	_
49-7	7323-7324	(	_
49-8	7325-7329	left	_
49-9	7330-7332	or	_
49-10	7333-7338	right	_
49-11	7339-7343	hand	_
49-12	7344-7345	)	_
49-13	7346-7348	as	_
49-14	7349-7357	possible	_
49-15	7358-7372	within-subject	_
49-16	7373-7379	factor	_
49-17	7380-7382	in	_
49-18	7383-7391	addition	_
49-19	7392-7394	to	_
49-20	7395-7401	domain	_
49-21	7402-7403	(	_
49-22	7404-7413	imitation	_
49-23	7414-7416	or	_
49-24	7417-7426	pantomime	_
49-25	7427-7428	)	_
49-26	7429-7432	and	_
49-27	7433-7441	category	_
49-28	7442-7443	(	_
49-29	7444-7454	transitive	_
49-30	7455-7456	,	_
49-31	7457-7469	intransitive	_
49-32	7470-7471	,	_
49-33	7472-7474	or	_
49-34	7475-7486	meaningless	_
49-35	7487-7488	)	_
49-36	7489-7490	.	_

Text=The only between-subject factor was group.
50-1	7491-7494	The	_
50-2	7495-7499	only	_
50-3	7500-7515	between-subject	_
50-4	7516-7522	factor	_
50-5	7523-7526	was	_
50-6	7527-7532	group	_
50-7	7533-7534	.	_

Text=As performing side did not show any significant effect, we conducted all subsequent analyses with total TULIA-score of the right hand only.
51-1	7535-7537	As	_
51-2	7538-7548	performing	_
51-3	7549-7553	side	_
51-4	7554-7557	did	_
51-5	7558-7561	not	_
51-6	7562-7566	show	_
51-7	7567-7570	any	_
51-8	7571-7582	significant	_
51-9	7583-7589	effect	_
51-10	7590-7591	,	_
51-11	7592-7594	we	_
51-12	7595-7604	conducted	_
51-13	7605-7608	all	_
51-14	7609-7619	subsequent	_
51-15	7620-7628	analyses	_
51-16	7629-7633	with	_
51-17	7634-7639	total	_
51-18	7640-7651	TULIA-score	_
51-19	7652-7654	of	_
51-20	7655-7658	the	_
51-21	7659-7664	right	_
51-22	7665-7669	hand	_
51-23	7670-7674	only	_
51-24	7675-7676	.	_

Text=We considered 2-tailed P <.05 to be significant after applying Benjamini-Hochberg procedure to account for multiple comparisons where appropriate in the analyses.
52-1	7677-7679	We	_
52-2	7680-7690	considered	_
52-3	7691-7699	2-tailed	_
52-4	7700-7701	P	_
52-5	7702-7703	<	_
52-6	7704-7707	.05	_
52-7	7708-7710	to	_
52-8	7711-7713	be	_
52-9	7714-7725	significant	_
52-10	7726-7731	after	_
52-11	7732-7740	applying	_
52-12	7741-7759	Benjamini-Hochberg	_
52-13	7760-7769	procedure	_
52-14	7770-7772	to	_
52-15	7773-7780	account	_
52-16	7781-7784	for	_
52-17	7785-7793	multiple	_
52-18	7794-7805	comparisons	_
52-19	7806-7811	where	_
52-20	7812-7823	appropriate	_
52-21	7824-7826	in	_
52-22	7827-7830	the	_
52-23	7831-7839	analyses	_
52-24	7840-7841	.	_

Text=To examine the neural correlates of gesture deficit at rest, we employed a ROI-to-ROI analysis.
53-1	7842-7844	To	_
53-2	7845-7852	examine	_
53-3	7853-7856	the	_
53-4	7857-7863	neural	_
53-5	7864-7874	correlates	_
53-6	7875-7877	of	_
53-7	7878-7885	gesture	_
53-8	7886-7893	deficit	_
53-9	7894-7896	at	_
53-10	7897-7901	rest	_
53-11	7902-7903	,	_
53-12	7904-7906	we	_
53-13	7907-7915	employed	_
53-14	7916-7917	a	_
53-15	7918-7928	ROI-to-ROI	_
53-16	7929-7937	analysis	_
53-17	7938-7939	.	_

Text=We entered age into the models as covariate of no interest, for age has been reported to influence gesture performance.
54-1	7940-7942	We	_
54-2	7943-7950	entered	_
54-3	7951-7954	age	_
54-4	7955-7959	into	_
54-5	7960-7963	the	_
54-6	7964-7970	models	_
54-7	7971-7973	as	_
54-8	7974-7983	covariate	_
54-9	7984-7986	of	_
54-10	7987-7989	no	_
54-11	7990-7998	interest	_
54-12	7999-8000	,	_
54-13	8001-8004	for	_
54-14	8005-8008	age	_
54-15	8009-8012	has	_
54-16	8013-8017	been	_
54-17	8018-8026	reported	_
54-18	8027-8029	to	_
54-19	8030-8039	influence	_
54-20	8040-8047	gesture	_
54-21	8048-8059	performance	_
54-22	8060-8061	.	_

Text=We compared connectivity between the groups using a general linear model with group and age as regressors and contrasted T-statistics with healthy controls vs patients.
55-1	8062-8064	We	_
55-2	8065-8073	compared	_
55-3	8074-8086	connectivity	_
55-4	8087-8094	between	_
55-5	8095-8098	the	_
55-6	8099-8105	groups	_
55-7	8106-8111	using	_
55-8	8112-8113	a	_
55-9	8114-8121	general	_
55-10	8122-8128	linear	_
55-11	8129-8134	model	_
55-12	8135-8139	with	_
55-13	8140-8145	group	_
55-14	8146-8149	and	_
55-15	8150-8153	age	_
55-16	8154-8156	as	_
55-17	8157-8167	regressors	_
55-18	8168-8171	and	_
55-19	8172-8182	contrasted	_
55-20	8183-8195	T-statistics	_
55-21	8196-8200	with	_
55-22	8201-8208	healthy	_
55-23	8209-8217	controls	_
55-24	8218-8220	vs	_
55-25	8221-8229	patients	_
55-26	8230-8231	.	_

Text=We applied analysis-level false discovery rate (FDR) -correction.
56-1	8232-8234	We	_
56-2	8235-8242	applied	_
56-3	8243-8257	analysis-level	_
56-4	8258-8263	false	_
56-5	8264-8273	discovery	_
56-6	8274-8278	rate	_
56-7	8279-8280	(	_
56-8	8281-8284	FDR	_
56-9	8285-8286	)	_
56-10	8287-8298	-correction	_
56-11	8299-8300	.	_

Text=Second, we tested the association of gesture performance with connectivity values in the ROI-pairs with significant group differences applying a partial Spearman correlation with age as covariate.
57-1	8301-8307	Second	_
57-2	8308-8309	,	_
57-3	8310-8312	we	_
57-4	8313-8319	tested	_
57-5	8320-8323	the	_
57-6	8324-8335	association	_
57-7	8336-8338	of	_
57-8	8339-8346	gesture	_
57-9	8347-8358	performance	_
57-10	8359-8363	with	_
57-11	8364-8376	connectivity	_
57-12	8377-8383	values	_
57-13	8384-8386	in	_
57-14	8387-8390	the	_
57-15	8391-8400	ROI-pairs	_
57-16	8401-8405	with	_
57-17	8406-8417	significant	_
57-18	8418-8423	group	_
57-19	8424-8435	differences	_
57-20	8436-8444	applying	_
57-21	8445-8446	a	_
57-22	8447-8454	partial	_
57-23	8455-8463	Spearman	_
57-24	8464-8475	correlation	_
57-25	8476-8480	with	_
57-26	8481-8484	age	_
57-27	8485-8487	as	_
57-28	8488-8497	covariate	_
57-29	8498-8499	.	_

Text=We conducted correlation analyses both within the whole sample and separately for each group.
58-1	8500-8502	We	_
58-2	8503-8512	conducted	_
58-3	8513-8524	correlation	_
58-4	8525-8533	analyses	_
58-5	8534-8538	both	_
58-6	8539-8545	within	_
58-7	8546-8549	the	_
58-8	8550-8555	whole	_
58-9	8556-8562	sample	_
58-10	8563-8566	and	_
58-11	8567-8577	separately	_
58-12	8578-8581	for	_
58-13	8582-8586	each	_
58-14	8587-8592	group	_
58-15	8593-8594	.	_

Text=To further examine effects of altered connectivity, we correlated FAB, TONI, AIMS, BFCRS, 5 factors of the PANSS, hallucination, and ego-disturbances according to CASH-present with connectivity in the ROI-pairs with significant group differences, applying partial Spearman correlation with age as covariate.
59-1	8595-8597	To	_
59-2	8598-8605	further	_
59-3	8606-8613	examine	_
59-4	8614-8621	effects	_
59-5	8622-8624	of	_
59-6	8625-8632	altered	_
59-7	8633-8645	connectivity	_
59-8	8646-8647	,	_
59-9	8648-8650	we	_
59-10	8651-8661	correlated	_
59-11	8662-8665	FAB	_
59-12	8666-8667	,	_
59-13	8668-8672	TONI	_
59-14	8673-8674	,	_
59-15	8675-8679	AIMS	_
59-16	8680-8681	,	_
59-17	8682-8687	BFCRS	_
59-18	8688-8689	,	_
59-19	8690-8691	5	_
59-20	8692-8699	factors	_
59-21	8700-8702	of	_
59-22	8703-8706	the	_
59-23	8707-8712	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
59-24	8713-8714	,	_
59-25	8715-8728	hallucination	_
59-26	8729-8730	,	_
59-27	8731-8734	and	_
59-28	8735-8751	ego-disturbances	_
59-29	8752-8761	according	_
59-30	8762-8764	to	_
59-31	8765-8777	CASH-present	_
59-32	8778-8782	with	_
59-33	8783-8795	connectivity	_
59-34	8796-8798	in	_
59-35	8799-8802	the	_
59-36	8803-8812	ROI-pairs	_
59-37	8813-8817	with	_
59-38	8818-8829	significant	_
59-39	8830-8835	group	_
59-40	8836-8847	differences	_
59-41	8848-8849	,	_
59-42	8850-8858	applying	_
59-43	8859-8866	partial	_
59-44	8867-8875	Spearman	_
59-45	8876-8887	correlation	_
59-46	8888-8892	with	_
59-47	8893-8896	age	_
59-48	8897-8899	as	_
59-49	8900-8909	covariate	_
59-50	8910-8911	.	_

